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sleeping – this phrase might seem funny, but not for those
who suffer from Narcolepsy. How many times I thought I was
living a real scene and when I woke up I found out that
everything was just another dream. Dream, fantasy, things of
my mind, like some people used to say, I did not know for
sure what was happening: just knew that it was something
new, strange and with no apparent explanation. Suddenly, an
incontrollable sleep and there I was, sleeping anywhere,
independently of the moment or the situation. Laziness,
tiredness, stress, I could not really explain the reason”
This text was written by Antônio Geraldo, a patient with
narcolepsy/cataplexy, hospitalized for fractures in both
ankles after falling from a stair with 5 meters high due to
excessive sleepiness.
We have evolved a lot in terms of knowledge about
narcolepsy. We already know the strong correlation between
genetics (presence of the allele HLA-DQB1n0602) and ambient
factors (viral infections and vaccinations), resulting in a
mechanism of autoimmunity [1–3]. There is also a major
knowledge of the illness's physiopathology with the discov-
ery of hypocretin and its connections with the Central
Nervous System from the lateral hypothalamus [4,5]. We
have evolved also in the pharmacological treatment with
the development of new drugs for the control of the excessive
diurnal sleepiness and of cataplexy [6,7]. However, the aver-
age time for the diagnosis is still above 10 years in men and
may be higher than 20 years in women, depending on the
country of origin [8].
The main factors responsible for this delay in diagnosis
and the beginning of treatment of these patients are the lack
of information and basic knowledge among the general
population, the failure in recognizing the signs and symp-
toms by the health professionals, besides the lack of Specia-
lized Centers for the diagnosis and treatment of narcolepsy
[9]. This delay in diagnosing takes most of these patients to a
life of hopelessness, prejudice and irreparable losses in
education and character development [10]. After diagnosis,
what we do is treat these patients with medications that
improve their sleepiness and the cataplexy. The treatment is
still purely symptomatic [6]. We do not modify the highder responsibility of Brazilian Association of Sleepprevalence of depression, neither, the progressive weight
gain which normally might lead to other complications
during the disease's evolution.
In this particular sense, some authors describe a higher
mortality rate among the narcoleptic population, although
the main causes are still undetermined [11]. A doctorate
thesis in our department has demonstrated that the aerobic
performance of these patients with narcolepsy was worse
than the performance found in patients with sleep obstruc-
tive apnea. This has led us to imagine a possible alteration in
the metabolism of these patients with probable impairment
of their quality of life. These data open several new scientiﬁc
horizons to be researched, but also bring much more respon-
sibility upon diagnosis and treatment of this disease.
Paraphrasing our patient, Antônio Geraldo: “Laziness,
tiredness, stress, I could not even explain”. Interestingly, we
also cannot explain!
This special text about narcolepsy brings to the reader a
very interesting panorama about narcolepsy. We have rele-
vant scientiﬁc knowledge, experience with dedicated groups
for the treatment and study of patients with narcolepsy,
besides several interesting clinical and mysterious cases.
We want to invite everyone to read, learn, spread and try to
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